VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
19 hedge funds and large institutions have $29.7M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2016 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
63% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 8
Holders
19
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.35M | |
| 2 | +$167K | |
| 3 | +$40K | |
| 4 |
Neuberger Berman Group
New York
|
+$26K |
| 5 |
KA
Klingman & Associates
New York
|
+$19K |
Top Sellers
| 1 | -$9.8M | |
| 2 | -$2.93M | |
| 3 | -$2.77M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$798K |
| 5 |
Goldman Sachs
New York
|
-$86K |